Replies to post #544661 on NorthWest Biotherapeutics Inc (NWBO)

[Dr Bala]

Checkmating 101 is futile after the outstanding P3 results and their publication in a top journal.

[hoffmann6383]

The more important point is that despite being blinded, they knew the results of the IA (as a fact) and other analysis (as an opinion, but I would be very certain). And changing endpoints after one knows the original failed is a huge issue.

1000% bullshit narrative per a federal court judge, 73+ trial docs and the company itself.

Have a great one Ex! by.

[HyGro]

The data lock -- the end of the trial, was announced 10/5/2020. NWBO announced they were changing the protocol in the 3/31/21 SEC filing.

The complete protocol, endpoints, comparators and SAP were all down AFTER the datalock, the completion of the trial. Very much appears to be changing the rules after the game.

The trial issues were not included in the JAMA manuscript submitted for peer-review. So many experts are only seeing the sanitized version of the trial, without all the warts. Don't think the regulators will be mislead.